206 related articles for article (PubMed ID: 22734439)
1. Developments in the prevention of transfusion-associated graft-versus-host disease.
Fast LD
Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
[TBL] [Abstract][Full Text] [Related]
2. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
[TBL] [Abstract][Full Text] [Related]
3. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
5. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products.
Mintz PD; Wehrli G
Bone Marrow Transplant; 2009 Aug; 44(4):205-11. PubMed ID: 19617907
[TBL] [Abstract][Full Text] [Related]
6. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
7. White blood cell inactivation after treatment with riboflavin and ultraviolet light.
Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP
Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease: introduction and prospect.
Ohto H; Suzuki H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
[TBL] [Abstract][Full Text] [Related]
10. Transfusion associated graft versus host disease.
Anwar M; Bhatti FA
J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
[TBL] [Abstract][Full Text] [Related]
11. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated graft-versus-host disease.
Rappeport JM
Yale J Biol Med; 1990; 63(5):445-54. PubMed ID: 2293503
[TBL] [Abstract][Full Text] [Related]
13. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?
Li M; Irsch J; Corash L; Benjamin RJ
Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055
[TBL] [Abstract][Full Text] [Related]
14. [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates].
Heim MU; Munker R; Sauer H; Wolf-Hornung B; Knabe H; Holler E; Böck M; Mempel W
Beitr Infusionsther; 1992; 30():178-81. PubMed ID: 1284701
[TBL] [Abstract][Full Text] [Related]
15. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.
Corash L; Lin L
Bone Marrow Transplant; 2004 Jan; 33(1):1-7. PubMed ID: 14647263
[TBL] [Abstract][Full Text] [Related]
16. Advances in transfusion therapy.
Beck SJ
Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion.
Higgins MJ; Blackall DP
Curr Hematol Rep; 2005 Nov; 4(6):470-6. PubMed ID: 16232385
[TBL] [Abstract][Full Text] [Related]
18. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
[TBL] [Abstract][Full Text] [Related]
19. [Transfusion-associated graft-vs-host disease].
Lillevang ST; Kristensen T
Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
